Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, HK | - |
dc.contributor.author | Doddareddy, MR | - |
dc.contributor.author | Cha, JH | - |
dc.contributor.author | Rhim, H | - |
dc.contributor.author | Cho, YS | - |
dc.contributor.author | Koh, HY | - |
dc.contributor.author | Jung, BY | - |
dc.contributor.author | Pae, AN | - |
dc.date.accessioned | 2024-01-21T06:36:09Z | - |
dc.date.available | 2024-01-21T06:36:09Z | - |
dc.date.created | 2021-09-04 | - |
dc.date.issued | 2004-08-01 | - |
dc.identifier.issn | 0968-0896 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/137322 | - |
dc.description.abstract | A small molecule library of piperazinylalkylisoxazole derivatives containing about 600 compounds was designed, synthesized and evaluated for blocking effects on T-type Ca2+ channel. Several ligands were identified to possess high inhibitory activity against the T-type Ca2+ channel. The compound 21 with trifluoromethyl substituents at C-3-position of phenyl group (W) and C-2-position of phenyl group (R-2) showed the highest inhibitory activity with IC50 value of 1.02 muM, which is comparable to that of mibefradil. (C) 2004 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | CALCIUM-CHANNELS | - |
dc.subject | RECEPTOR LIGANDS | - |
dc.subject | CLONED HUMAN | - |
dc.subject | DOPAMINE | - |
dc.subject | ANTAGONIST | - |
dc.subject | INHIBITION | - |
dc.subject | EFFICACY | - |
dc.subject | CURRENTS | - |
dc.subject | AGONIST | - |
dc.subject | DESIGN | - |
dc.title | Synthesis and biological evaluation of novel T-type Ca2+ channel blockers | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bmc.2004.06.011 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY, v.12, no.15, pp.3965 - 3970 | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY | - |
dc.citation.volume | 12 | - |
dc.citation.number | 15 | - |
dc.citation.startPage | 3965 | - |
dc.citation.endPage | 3970 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000222886700001 | - |
dc.identifier.scopusid | 2-s2.0-3042831495 | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | CALCIUM-CHANNELS | - |
dc.subject.keywordPlus | RECEPTOR LIGANDS | - |
dc.subject.keywordPlus | CLONED HUMAN | - |
dc.subject.keywordPlus | DOPAMINE | - |
dc.subject.keywordPlus | ANTAGONIST | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | CURRENTS | - |
dc.subject.keywordPlus | AGONIST | - |
dc.subject.keywordPlus | DESIGN | - |
dc.subject.keywordAuthor | T-type calcium channel | - |
dc.subject.keywordAuthor | synthesis | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.